Printer Friendly

Browse Bevacizumab topic


1-300 out of 497 article(s) nextnext page
Title Author Type Date Words
AstraZeneca receives double EU recommendation for cancer drug. Sep 22, 2020 341
LONDON BRIEFING: HSBC And StanChart Under Pressure Over Fraud, China. Sep 21, 2020 1715
TOP NEWS: Astra's Lynparza Gets EU Ok For Ovarian And Prostate Cancer. Sep 21, 2020 229
Seattle Genetics, Genmab Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020. Sep 21, 2020 584
Seattle Genetics, Genmab presents data from innovaTV 204 phase 2 trial. Sep 21, 2020 482
LONDON MARKET PRE-OPEN: Lower Start Seen; Informa Posts Interim Loss. Financial report Sep 21, 2020 1603
ImmunoGen announces final data from FOWARD II trial at ESMO. Sep 17, 2020 279
Mersana reports interim Phase 1 data of XMT-1536. Sep 17, 2020 272
NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients. Sep 11, 2020 803
Outlook Therapeutics reports topline results from NORSE 1 study. Aug 26, 2020 432
Bio-Thera Solutions, BeiGene Ink License, Distribution, and Supply Agreement for Avastin Biosimilar BAT1706 in China. Aug 24, 2020 370
Outcomes after 23G trans-conjunctival parsplana vitrectomy and suturing of sclerotomy using 10/0 Nylon in patients with diabetic retinopathy in private hospital of Sargodha. Zaheer, Bilal; Zaheer, Waqas Report Aug 14, 2020 1577
This drug buys me time with my family.. but I worry the money will run out. It's soul-destroying cancer patients in other parts of the UK can pay much less; SERIOUSLY ILL MUM CHARGED FOUR TIMES AS MUCH NORTH OF THE BORDER FOR LIFE-EXTENDING MEDICINE Desperate mother-of-two is running out of cash to fund her vital treatment. John Ferguson / Political Editor Aug 2, 2020 1107
Integrative Oncology Research Update from Green, Jen Aug 1, 2020 1820
Increased expressions of cellular ATP-binding cassette transporters may be a promising diagnostic marker for colorectal cancer. Qutub, Renad M.; Al-Ghafari, Ayat B.; Al Doghaither, Huda A.; Omar, Ulfat M.; Ghulam, Jihan M. Aug 1, 2020 4997
Simultaneous Presentation of Uveitic Disc Edema and Papilledema in an Adult. Liaboe, Chase A.; Lee, Michael S.; Yamanuha, Justin J.Y. Jul 31, 2020 2320
Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer. Kawagoe, Tetsuro; Ikeda, Go; Oshiro, Yu; Maruki, Yuta; Kaneko, Keiko; Iwakiri, Katsuhiko Jul 31, 2020 2171
Aravive completes Phase 1b trial of AVB-500 in PROC. Jul 23, 2020 806
'The support has been overwhelming'. Jul 2, 2020 286
Molecular Targeted Cancer Therapies and the Kidney. Aksu, Ozge Bas; Sadioglu, Rezzan Eren; Sengul, Sule Jul 1, 2020 6275
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment. Roviello, Giandomenico; Casadei-Gardini, Andrea; Nobili, Stefania; Mini, Enrico; Fancelli, Sara Jun 30, 2020 2525
Identification of PDLl-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors. Wu, Yanping; Lin, Lianjun; Liu, Xinmin Jun 30, 2020 5697
Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion. Song, Wenqi; Jiao, Wanzhen; Li, Fengjiao; Ma, Aihua; Zhao, Bojun Clinical report Jun 30, 2020 4335
Annexin A2 Expression in the Aerogenous Spread of Pulmonary Invasive Mucinous Adenocarcinoma with Gastric Lineage. Arai, Kazumori; Iwasaki, Tomohiro; Tsuchiya, Chinatsu; Sonoda, Akihiro Jun 30, 2020 4671
Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer. Sasaki, Akinori; Harano, Kenichi; Kogawa, Takahiro; Matsubara, Nobuaki; Naito, Yoichi; Hosono, Ako; Jun 30, 2020 2182
Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate. Kasuya, Yuka; Sano, Ichiya; Makino, Shinji; Kawashima, Hidetoshi Jun 30, 2020 1776
Malignant Astroblastoma. Sarper, Binnaz; Bayrak, Busra Yaprak; Halis, Hatice; Alparslan, Burcu; Bayraktar, Hulya Yeni Jun 30, 2020 958
NMPA Accepts Bio-Thera Solutions' Biologics License Application for BAT1706, A Proposed Biosimilar to Avastin. Jun 23, 2020 477
Bio-Thera Solutions submits BAT1706 BLA with NMPA for multiple cancers. Jun 22, 2020 176
Bio-Thera Solutions submits BAT1706 BLA with NMPA for multiple cancers. Jun 22, 2020 180
Outlook Therapeutics expects topline results from NORSE 1 study in August. Jun 17, 2020 510
Roche's Tecentriq in combination with Avastin gains FDA approval for most common liver cancer. Jun 3, 2020 225
Roche's Tecentriq in combination with Avastin gains FDA approval for most common liver cancer. Jun 3, 2020 229
Roche's Tecentriq Approved In US For Most Common Form Of Liver Cancer. Jun 2, 2020 346
LONDON BRIEFING: Tesco's Finance Boss Alan Stewart To Retire. Jun 2, 2020 1674
GLOBAL TOP NEWS SUMMARY: European Stocks Shrug Off US Unrest. Jun 2, 2020 1824
Should all patients with advanced ovarian cancer receive frontline maintenance therapy? Rossi, Emma Jun 1, 2020 1388
Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer/Metastatik ve rekurren serviks kanser tanili Turk hastalarda bevasizumabin etkinlik ve guvenligi. Ercelep, Ozlem; Tataroglu, Deniz; Ozcelik, Melike; Surmeli, Heves; Degirmenci, Mustafa; Inanc, Mevlu Jun 1, 2020 2799
Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV. Li, Fengjiao; Ma, Aihua; Zhao, Bojun May 31, 2020 3776
The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis. Nie, Run-Cong; Zhao, Chong-Bang; Xia, Xiao-Wei; Luo, Ying-Shan; Wu, Ting; Zhou, Zhi-Wei; Yuan, Shu-Q Report May 31, 2020 6865
Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study. Elnahry, Ayman G.; Abdel-Kader, Ahmed A.; Raafat, Karim A.; Elrakhawy, Khaled Clinical report May 31, 2020 10044
Microcornea and Thickened Lens in Angle Closure following Nonsurgical Treatment of Retinopathy of Prematurity. Chang, Ta. C.; Tran, Kimberly D.; Cernichiaro-Espinosa, Linda A.; Leung, Ella H.; Grajewski, Alana L May 31, 2020 4824
Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells. Sun, Xiaodan; Li, Ji; Li, Yizhuo; Wang, Shouhan; Li, Qingchang May 31, 2020 8332
ImmunoGen announces initial data from FORWARD II study at ASCO. May 29, 2020 276
Merck study shows KEYTRUDA reduced risk of progression, death by 40%. May 28, 2020 248
Outlook Therapeutics expects topline results from NORSE 1 study in 3Q20. May 15, 2020 379
Customized disposable kit versus a conventional stainless steel instrument for an intravitreal injection: A comparison. Khaqan, Hussain Ahmad; Imtiaz, Usman; Malik, Irfan Qayyum; Qureshi, Bilal Zaheer; Ateeq-ur-Rehamn Report May 12, 2020 2288
AstraZeneca receives US approval for a combination with Lynparza in advanced ovarian cancer. May 12, 2020 336
LONDON MARKET PRE-OPEN: Diploma And Victrex Pull Interim Dividends. May 11, 2020 943
LONDON BRIEFING: Shares Up As UK Starts To Creep Out Of Lockdown. May 11, 2020 1278
AstraZeneca Secures US Approvals, Recovers Rights To Brazikumab. May 11, 2020 306
GLOBAL TOP NEWS SUMMARY: Stocks Slip Even As Lockdowns Start To Ease. May 11, 2020 1596
UK TOP NEWS SUMMARY: Heathrow Passenger Numbers Down 97% In April. May 11, 2020 1219
AstraZeneca, Merck announce FDA approval of LYNPARZA/bevacizumab combination. May 11, 2020 153
Myriad Genetics receives FDA approval of myChoice CDx as companion for Lynparza. May 11, 2020 161
A Rare Cause of Type II Neovascularization: Unilateral Retinal Pigment Epithelium Dysgenesis. Gediz, Berrak Sekeryapan May 1, 2020 1203
Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study. Li, Chaofeng; Tang, Tao; Wang, Wenyue Clinical report Apr 30, 2020 4156
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis. Schoffski, P.; Timmermans, I.; Hompes, D.; Stas, M.; Sinnaeve, F.; De Leyn, P.; Coosemans, W.; Van R Apr 30, 2020 5814
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer. Zhu, Liuying; Wang, Yuanhe; Zhou, Yang; Dong, Qian; Liu, Yunpeng; Zhang, Jingdong Apr 30, 2020 4465
Systemic Factors Associated with Treatment Response in Diabetic Macular Edema. Wong, Wendy Meihua; Chee, Caroline; Bhargava, Mayuri; Chai, Charmaine; Lin, Hazel; Zhao, Paul; Mangu Clinical report Apr 30, 2020 4190
Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments. Furino, Claudio; Grassi, Maria Oliva; Bini, Vito; Nacucchi, Annalisa; Boscia, Francesco; Reibaldi, M Apr 30, 2020 2982
Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis. Sun, Xiaolei; Zhang, Jingjing; Tian, Jingyi; Chen, Shijiu; Zeng, Fanxing; Yuan, Gongqiang Apr 30, 2020 5172
Four-Year Outcome of Aflibercept Treatment-Naive Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting. Gayadine-Harricham, Yanel; Rufin, Virginie; Law-Koune, Sandrine; Tran, Thi Ha Chau Apr 30, 2020 5196
Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature. Kaya, Erin A.; Carlson, Jonathan D.; Thomas, Cheddhi J.; Wagner, Aaron E.; Fairbanks, Robert K.; Lam Apr 30, 2020 3903
Clinicopathological characteristics of patients with surgically resected lung cancer having tumours harboring anaplastic lymphoma kinase fusion protein. Chen, Bo; Jiang, Zhiming; Li, Chenghui; Lu, Hongyang Report Apr 30, 2020 1951
MediciNova receives notice of allowance for new patent covering MN-166. Apr 20, 2020 172
Outlook Therapeutics sees no COVID-19 impact on NORSE 1, delays to NORSE 2. Apr 14, 2020 246
Double whammy: A rare disorder complicating a common infection - A case report and review of literature. Devaraj, Uma; Ramachandran, Priya; Maheswari K., Uma Report Apr 3, 2020 2914
Oncolytics' pelareorep shows positive safety and efficacy results in publication. Apr 2, 2020 202
Osler-Weber-Rendu Disease Uncovered by Preeclampsia in a Case Report. Ouachaou, Jamal; Mimouni, Hamza; Maarad, Mohammed; Mellagui, Yassine; Amar, Asmae Oulad; Bkiyar, Hou Mar 31, 2020 2003
Unusual Presentation of Bilateral Radiation-Induced Angiosarcoma of the Breast. Jayarajah, Umesh; Nagodavithane, Kavinda; Basnayake, Oshan; Seneviratne, Sanjeewa Mar 31, 2020 1896
Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab. Tao, Chi-Wei; Chen, Mei-Yin; Tseng, Ching-Min; Lapke, Nina; Chen, Shu-Jen; Tan, Kien Thiam Report Mar 31, 2020 2823
Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy. Ameku, Koken; Higa, Mariko Mar 31, 2020 4552
Optic Coherence Tomography Angiography Findings of Bilateral Choroidal Neovascularization Associated with Optic Disc Drusen Treated with Intravitreal Aflibercept Injection. Akidan, Melih; Bulut, Mehmet; Yaprak, Lutfiye; Erol, Muhammet Kazim; Suren, Elcin Mar 31, 2020 4220
Glucose-Regulated Protein 78 in the Aqueous Humor of Patients with Diabetic Macular Edema. Choi, Moon Young; Kwon, Jin-woo Mar 31, 2020 4446
Mersana Therapeutics updates data from XMT-1536 Phase 1 dose escalation study. Mar 30, 2020 292
With Diabetes, Keep an Eye on Your Vision: Stay on guard against diabetic. Mar 24, 2020 755
VBL Therapeutics expects interim analysis of OVAL Phase 3 study in 1Q20. Mar 19, 2020 174
Agenus awarded FDA's Fast Track designation for balstilimab & zalifrelimab for the treatment of advanced cervical cancer. Mar 13, 2020 172
Agenus awarded FDA's Fast Track designation for balstilimab & zalifrelimab for the treatment of advanced cervical cancer. Mar 13, 2020 168
Gynecologic cancer. Zhou, Zhen Ni; Wright, Jason D. Mar 1, 2020 3294
Anti-Vascular Endothelial Growth Factors as a Potential Risk for Implant Failure: A Clinical Report. Emami, Elham; de Grandmont, Pierre; Menassa, Melanie; Audy, Nicholas; Durand, Robert Clinical report Mar 1, 2020 2302
Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up. Nicula, Cristina; Nicula, Dorin; Rednik, Anca; Bulboaca, Adriana; Crisan, Ovidiu Clinical report Mar 1, 2020 5723
Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab. Bilgic, Alper; Kodjikian, Laurent; Chhablani, Jay; Sudhalkar, Anand; Trivedi, Megha; Vasavada, Viraj Mar 1, 2020 6598
Seven-Year Visual and Anatomical Outcomes of Intravitreal Vascular Endothelial Growth Factor Inhibition for Neovascular Age-Related Macular Degeneration. Stattin, Martin; Forster, Julia; Ahmed, Daniel; Haas, Anna-Maria; Graf, Alexandra; Krepler, Katharin Mar 1, 2020 4267
Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial. Bilgic, Alper; Sudhalkar, Aditya; Sudhalkar, Anand; Trivedi, Megha; Vasavada, Viraj; Vasavada, Shail Mar 1, 2020 6197
Increased Temperature Facilitates Adeno-Associated Virus Vector Transduction of Colorectal Cancer Cell Lines in a Manner Dependent on Heat Shock Protein Signature. Bienkowska, Alicja; Kuzmicka, Weronika; Ciepiela, Olga; Ochocki, Justyn; Malecki, Maciej Mar 1, 2020 7892
A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine. Chahin, Michael; Krishnan, Nithya; Chhatrala, Hardik; Shaikh, Marwan Mar 1, 2020 2011
Ibrutinib-Induced Vasculitis in a Patient with Metastatic Colon Cancer Treated in Combination with Cetuximab. Chi, Jeffrey; Park, Jennifer; Saif, Muhammad Wasif Mar 1, 2020 2251
Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus. Wang, Connor; Rose, Stephen; Gettle, Lori Mankowski; Spencer, Ryan Mar 1, 2020 3460
Photodynamic Therapy of Presumed Choroidal Metastasis Secondary to Colorectal Carcinoma: Literature Review. Neto, Laurentino Biccas; Pulido, Jose Z.; Melo, Gustavo B.; Lima, Luiz H.; Rodrigues, Eduardo B. Mar 1, 2020 3965
Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block. Khan, Alisha; Riaz, Sana; Carhart, Robert, Jr. Mar 1, 2020 1999
Extracellular Vesicles Involvement in the Modulation of the Glioblastoma Environment. Ciccocioppo, Fausta; Lanuti, Paola; Marchisio, Marco; Miscia, Sebastiano Mar 1, 2020 6056
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy. Huang, Chun-Ming; Huang, Ching-Wen; Ma, Cheng-Jen; Yeh, Yung-Sung; Su, Wei-Chih; Chang, Tsung-Kun; T Mar 1, 2020 6939
Is Tocilizumab A Risk Factor for Lower Gastrointestinal Perforations? Isolated Cecal Necrosis: A Rare Case Report/Tocilizumab; Alt Gastrointestinal Sistem Perforasyonlari icin Bir Risk Faktoru Mu? Izole Cekum Nekrozu: Nadir Bir Olgu Sunumu. Avci, Emran Kuzey; Atici, Semra Demirli; Ekmekci, Sumeyye; Arican, Can; Kaya, Tayfun; Tugmen, Cem Mar 1, 2020 2066
EDITORIAL. Egrilmez, Sait Editorial Mar 1, 2020 1332
Unusual Association of Inverse Retinitis Pigmentosa, Scleromalacia, and Neovascular Glaucoma. Altintas, Ayge Gul Kocak; Ilhan, Cagri; Citirik, Mehmet Mar 1, 2020 2069
Clinical Evaluation of Efficacy and Safety of Metformin add-on Therapy to Standard ATT in Newly Diagnosed Pulmonary Tuberculosis Patients. Abinaya, E.; Meenakshi, N.; Ruckmani, A.; Nisha, A. Nasrin; Lella, Tanuja; Arunkumar, R. Report Mar 1, 2020 6052
Isofol Medical AB begins treatment of first patient in Japan under Phase 3 AGENT Study of arfolitixorin. Feb 19, 2020 254
Isofol Medical AB begins treatment of first patient in Japan under Phase 3 AGENT Study of arfolitixorin. Feb 19, 2020 258
Bio-Thera Solutions Touts Positive Top-Line Results for BAT1706, A Proposed Biosimilar to Avastin. Feb 5, 2020 406
Study Suggests Delta-Tocotrienol in Combination with Standard Therapy Increased Survival in Refractory Ovarian Cancer Patients. Feb 1, 2020 819
Cancer Immunotherapy Market Size Is Expected to Reach USD 101.6 Billion at a 14.8% CAGR By 2023. Jan 21, 2020 860
Lynparza regulatory submission granted Priority Review in the US for 1st-line maintenance treatment with bevacizumab in advanced ; Submission based on Phase III PAOLA-1 trial for patients with advanced ovarian cancer regardless of biomarker status or ... Jan 13, 2020 264
Mundipharma collaborates with Samsung Bioepis. Jan 13, 2020 117
Mundipharma collaborates with Samsung Bioepis. Jan 13, 2020 113
TOP NEWS: Astra Ends Epanova Trial; Lynparza Gets US Priority Review. Jan 13, 2020 372
LONDON BRIEFING: AstraZeneca To Take Hit After Epanova Trial Halted. Jan 13, 2020 1542
Global Brain Tumor Drugs Market Trends, Share & Scope, Product Estimates & Strategy Framework To 2018-2028: Radiant Insights, Inc. Jan 7, 2020 708
TOT BIOPHARM Biological Drug R&D Project Makes List of National Major Scientific and Technological Special Projects for "Significant New Drug Development". Jan 2, 2020 371
Should secondary cytoreduction be performed for platinum-sensitive recurrent ovarian cancer? Toboni, Michael D.; Mutch, David G. Clinical report Jan 1, 2020 1654
Fluorescein Angiographic Findings of Peripheral Retinal Vasculature after Intravitreal Conbercept versus Ranibizumab for Retinopathy of Prematurity. Jin, Enzhong; Yin, Hong; Gui, Yufei; Chen, Juan; Zhang, Jian; Liang, Jianhong; Li, Xiao-xin; Zhao, M Jan 1, 2020 6152
Overview of Colon Cancer for the Medical-Surgical Nurse. Moe, Linda; Bohnenkamp, Susan Medical condition overview Jan 1, 2020 2309
Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report. Mendiola, Vincent Louie; Kesireddy, Meghana; Jana, Bagi Jan 1, 2020 2213
Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury. Touzani, F.; Geers, C.; Pozdzik, A. Jan 1, 2020 1870
Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial. Fazel, Farhad; Nikpour, Hossein; Pourazizi, Mohsen Jan 1, 2020 2978
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010-2016. Scondotto, Giulia; Sultana, Janet; Ientile, Valentina; Ingrasciotta, Ylenia; Fontana, Andrea; Copett Clinical report Jan 1, 2020 5790
Contemporary Tailored Oncology Treatment of Biliary Tract Cancers. Turkes, Fiona; Carmichael, Juliet; Cunningham, David; Starling, Naureen Disease/Disorder overview Dec 31, 2019 10108
Aqueous Humor Cytokine Levels in Diabetic Macular Edema Patients with Cotton-Wool Spots. Park, Young-Gun; Jee, Donghyun; Kwon, Jin-woo Dec 31, 2019 3876
Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer. Sun, Xiaowen; Gan, Lu; Na, Aru; Ge, Lingling; Chen, Baoqing; Liu, Jiaming Dec 31, 2019 9231
Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application. Shi, Yuan-Xiang; Sheng, De-Qiao; Cheng, Lin; Song, Xin-Yu Dec 31, 2019 8385
Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy. Yang, Jingyuan; Yuan, Mingzhen; Xia, Song; Chen, Youxin Dec 31, 2019 5241
Association between Hyperreflective Foci on Spectral-Domain Optical Coherence Tomography and Early Recurrence of Diabetic Macular Edema after Intravitreal Dexamethasone Implantation. Kim, Kyung Tae; Kim, Dong Yoon; Chae, Ju Byung Dec 31, 2019 7294
An Exceptional Responder to Nivolumab in Metastatic Non-Small-Cell Lung Cancer: A Case Report and Literature Review of Long-Term Survivors. Baseri, Babak; Samra, Bachar; Tam, Eric; Chiu, Edwin; Leaf, Andrea Dec 31, 2019 4860
Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma. Petersons, Richard A.; Kashyap, Bhavani; Pawloski, Pamala A.; Forsberg, Anna C.; Hanson, Leah R. Dec 31, 2019 4408
Effect of oral eplerenone in anatomical and functional improvement in patients with chronic central serous chorioretinopathy. Omer Farooq, Asad Habib, Masood Alam Shah and Najia Ahmed Dec 31, 2019 2404
Continuing Full Induction Regimen Not Beneficial in Metastatic CRC; Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival. Dec 20, 2019 268
Chordoma Disease Market: Diagnosis and Treatment 2020 to Encounter Countless Growth Opportunities / Promising Growth Opportunities With Global Key Companies. Dec 19, 2019 922
Addition of Maintenance Olaparib Slows Advanced Ovarian Cancer; Benefit substantial for homologous-recombination deficiency positive tumors with, without BRCA mutations. Dec 18, 2019 293
TOT BIOPHARM Included in the "Suzhou Industrial Park - 2019 Awarded Listed Enterprises". Dec 16, 2019 516
Global Colorectal Cancer Drugs Market Report 2020 with Profiles of Merck & Co. Inc, Roche, Sanofi, Amgen, Pfizer. Report Dec 12, 2019 758
Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib. Report Dec 11, 2019 983
Global Ovarian Cancer Drugs Market Report 2020: Focus on Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumour, Germ Cell Tumour, Sex Cord-Stromal Tumou. Report Dec 11, 2019 1002
Global Kidney Cancer Drugs Market Report 2020: Focus on Nexavar, Sutent, Afinitor, Votrient, Avastin, Inlyta, Torisel, Proleukin. Report Dec 11, 2019 989
FDA approves Roche's Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer. Dec 4, 2019 1548
Global Cancer Immunotherapy Market: $100+ Billion Analysis & Forecast 2020-2023. Dec 4, 2019 1496
How should we monitor for ovarian cancer recurrence? Rossi, Emma Dec 1, 2019 1152
Solitary Colorectal Cancer Metastasis to the Pancreas. Karageorgou, M.; Myoteri, D.; Kotsis, T.; Polymeneas, G.; Bournakis, E.; Dellaportas, D. Report Nov 30, 2019 1926
Does Tumour Contrast Retention on CT Immediately Post Chemoembolization Predict Tumour Metabolic Response on FDG-PET in Patients with Hepatic Metastases from Colorectal Cancer? Tan, K.T.; Rakheja, R.; Plewes, C.; Mondal, P.; Lim, H.; Ahmed, S.; Lee, E.; Otani, R.; Luo, Y.; Sha Nov 30, 2019 3025
As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization plus Sorafenib. Liu, Lei; Wang, Enxin; Li, Lin; Chen, Dongyu; Peng, Kun; Wang, Mengmeng; Han, Guohong Nov 30, 2019 5098
Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy. Chen, Hui-Jin; Ma, Zhi-Zhong; Li, Ying; Wang, Chang-Guan Nov 30, 2019 4996
In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery. Zhang, Yuanyuan; Zhu, Shaopin; Xu, Xun; Zuo, Lei Nov 30, 2019 6540
Internal Limiting Membrane Peeling for Persistent Submacular Fluid after Successful Repair of Diabetic Tractional Retinal Detachment. Jung, Byung Ju; Jeon, Sohee; Lee, Kook; Baek, Jiwon; Lee, Won Ki Nov 30, 2019 3806
Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results--A Retrospective, Comparative Study. Erden, Burak; Bolukbasi, Selim; Bas, Emine; Cakir, Akin Nov 30, 2019 3863
Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers. Ge, Yang; Westphalen, C. Benedikt; Ma, Wen Wee; Vega, Kenneth J.; Weygant, Nathaniel Disease/Disorder overview Nov 30, 2019 9178
Roche reports positive results from phase three Tecentriq trial in combination with Avastin. Nov 26, 2019 162
Roche reports positive results from phase three Tecentriq trial in combination with Avastin. Nov 26, 2019 158
Kidney Cancer Drugs Market - Asia Pacific To Register The Highest CAGR During 2018-2022. Nov 26, 2019 684
Chordoma Disease Market 2019 Global Size, Industry Share, Revenue, Developments, Key Players, Future Plans and Regional Trends by Forecast 2023. Nov 20, 2019 853
FDA Accepts Samsung Bioepis' BLA for SB8 Bevacizumab Biosimilar Candidate. Nov 20, 2019 165
Merck (MRK). Nov 14, 2019 3570
GlaxoSmithKline (LSE: GSK). Nov 11, 2019 16581
Merck & Co (NYSE:MRK). Nov 11, 2019 3153
Merck (MRK). Nov 7, 2019 3569
Global Neuroendocrine Tumors (NETs) Market Insights, Epidemiology and Market Forecasts, 2017-2018 & 2019-2028. Nov 7, 2019 1126
VBL Therapeutics announces new IND for Phase 2 trial of VB-111 in rGBM. Nov 6, 2019 186
GlaxoSmithKline (LSE: GSK). Nov 6, 2019 16607
Biocon's Biologics drug products facility gets nod from US FDA. ANI Nov 5, 2019 334
GlaxoSmithKline (LSE: GSK). Nov 4, 2019 16581
Merck & Co. (NYSE: MRK). Nov 4, 2019 3149
What Medical-Surgical Nurses Need to Know About Caring for Patients with Epithelial Ovarian Cancer: Part II. Bohnenkamp, Susan; McClung, Emily; Bohnenkamp, Zachary Nov 1, 2019 4241
Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes. Ozdemir, Huseyin Baran; Hasanreisoglu, Murat; Yiiksel, Murat; Ertop, Mestan; Gurelik, Gokhan; Ozdek, Nov 1, 2019 3267
The Relationship Between Vasoproliferative Tumor and Uveitis in a Multiple Sclerosis Patient: A Case Report and Review of the Literature. Ozalp, Onur; Atalay, Eray; Bilgec, Mustafa Deger; Erol, Nazmiye; Yildirim, Nilgun Nov 1, 2019 1998
Protect Your Sight if You Have Diabetes: As many as 45 percent of Americans with diabetes have a condition called diabetic retinopathy, but many are not aware of it. Nov 1, 2019 890
Acute perforated appendicitis due to metastatic small-cell lung cancer. Keramidaris, Dimitrios; Oikonomou, Christianna; Theodorolea, Kyriaki; Mohamed, Tahira; Gourgiotis, S Letter to the editor Nov 1, 2019 745
Acute perforated appendicitis due to metastatic smaii-ceii lung cancer. Keramidaris, Dimitrios; Oikonomou, Christianna; Theodorolea, Kyriaki; Mohamed, Tahira; Gourgiotis, S Letter to the editor Nov 1, 2019 744
Vascular Endothelial Growth Factor Is Regulated by the Canonical and Noncanonical Transforming Growth Factor-[beta] Pathway in Synovial Fibroblasts Derived from Osteoarthritis Patients. Takano, Shotaro; Uchida, Kentaro; Shoji, Shintaro; Itakura, Makoto; Iwase, Dai; Aikawa, Jun; Mukai, Oct 31, 2019 3517
A Rare Case of Cyclophosphamide-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-GBM Vasculitis, and Review of Current Literature. Nisar, Taha; Alchaki, Abdul R.; Feinstein, Erin Oct 31, 2019 2763
Nanovectors Design for Theranostic Applications in Colorectal Cancer. Rampado, Riccardo; Crotti, Sara; Caliceti, Paolo; Pucciarelli, Salvatore; Agostini, Marco Oct 31, 2019 16875
One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial. Wang, Fenghua; Yuan, Yuanzhi; Wang, Ling; Ye, Xiaofeng; Zhao, Jingke; Shen, Mengxi; Zhang, Qi; Xu, D Clinical report Oct 31, 2019 4404
Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice. Garcia-Layana, A.; Garcia-Arumi, J.; Figueroa, M.S.; Barquet, L. Arias; Ruiz-Moreno, J.M.; Monclus-A Oct 31, 2019 6094
Seattle Genetics (NASDAQ: SGEN). Oct 30, 2019 1843
GlaxoSmithKline (LSE: GSK). Oct 29, 2019 16571
GlaxoSmithKline (LSE: GSK). Oct 28, 2019 16578
Chugai Pharmaceutical Co., Ltd. - Tecentriq in Combination with Avastin Increases Overall Survival and Progression-free Survival as an Initial Treatment in People with Unresectable Hepatocellular Carcinoma -- 21/10/2019. Oct 22, 2019 241
GlaxoSmithKline (LSE: GSK). Oct 22, 2019 16570
Trovagene announces data from Phase 1b/2 trial of onvansertib. Oct 22, 2019 104
Chordoma Disease Market 2019 Trends, Statistics, Size, Share, Key Companies, Growth, And Regional Outlook To 2023. Oct 21, 2019 978
Roche's Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma. Oct 21, 2019 1465
United States Biosimilar Monoclonal Antibodies Market Report 2019: Prospects, Trends Analysis, Market Size and Forecasts up to 2024. Report Oct 21, 2019 626
GlaxoSmithKline (LSE: GSK). Oct 21, 2019 16574
Patient Cost Responsibility Up for Guideline-Discordant Care; Guideline-discordant tx linked to $1,841 higher patient costs in first year in metastatic breast cancer. Oct 18, 2019 249
Seattle Genetics (NASDAQ: SGEN). Oct 17, 2019 1994
GlaxoSmithKline (LSE: GSK). Oct 15, 2019 16569
Biosimilar's Market 2019: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025. Oct 10, 2019 713
Cancer Monoclonal Antibodies Market 2019: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025. Oct 10, 2019 699
Seattle Genetics (NASDAQ: SGEN). Oct 9, 2019 1805
GlaxoSmithKline (LSE: GSK). Oct 8, 2019 16574
Mereo BioPharma receives FDA Fast Track designation for navicixizumab. Oct 7, 2019 132
ImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination with Carboplatin and Avastin at ESMO. Oct 2, 2019 385
GlaxoSmithKline (LSE: GSK). Oct 2, 2019 16570
Seattle Genetics (NASDAQ: SGEN). Oct 2, 2019 1843
A Specialized Orthosis for Suppressing Bony Destruction from Multiple Myeloma and to Enhance Healing of a Pathologic Fracture in an Appendicular Lesion. Chisena, Ernest C.; Edelstein, Yudell; Chisena, Robert S. Oct 1, 2019 3337
FTSE 100 closes modestly lower as sterling ticks higher; US stocks recover from Friday drop. Oct 1, 2019 3075
AstraZeneca reports Lynparza improved amount of time women lived without disease progression in newly-diagnosed advanced ovarian cancer. Oct 1, 2019 393
AstraZeneca reports Lynparza improved amount of time women lived without disease progression in newly-diagnosed advanced ovarian cancer. Oct 1, 2019 389
Lynparza Phase 3 PAOLA-1 Trial Significantly Increased Progression-Free Survival as First-Line Maintenance Treatment with Bevacizumab for Newly-Diagnosed Advanced Ovarian Cancer. Oct 1, 2019 175
Lynparza improved the time women lived without disease progression to 22 months in the broad population and to 37 months in HRD-positive patients as 1st-line maintenance treatment with bevacizumab for newly-diagnosed advanced ovarian cancer. Sep 30, 2019 712
Samsung Bioepis Co reveals results from Phase three study assessing SB8. Sep 30, 2019 291
Samsung Bioepis Co reveals results from Phase three study assessing SB8. Sep 30, 2019 287
AstraZeneca Notes Positive Results For Trials Of Lynparza And Tagrisso. Sep 30, 2019 469
Signet Ring Cell Carcinoma of the Colon in Young Adults: A Case Report and Literature Review. Farraj, Farida Abi; Sabbagh, Hadi; Aridi, Tarek; Fakhruddin, Najla; Farhat, Fadi Sep 30, 2019 5020
Prolonged Treatment Response to Pembrolizumab in a Patient with Pretreated Metastatic Colon Cancer and Lynch Syndrome. Keating, Matthew; Giscombe, Lisa; Tannous, Toufic; Hartshorn, Kevan Sep 30, 2019 2638
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors. Schepisi, Giuseppe; Brighi, Nicole; Cursano, Maria Concetta; Gurioli, Giorgia; Ravaglia, Giorgia; Al Sep 30, 2019 8889
Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. Velayati, Sara; Erinjeri, Joseph P.; Brody, Lynn A.; Ziv, Etay; Boas, Franz E.; Brown, Karen T.; Cov Sep 30, 2019 4002
[EpCAM.sup.low] Circulating Tumor Cells: Gold in the Waste. Nicolazzo, Chiara; Gradilone, Angela; Loreni, Flavia; Raimondi, Cristina; Gazzaniga, Paola Sep 30, 2019 3568
Merck, AstraZeneca announced detailed results from Phase 3 PAOLA-1 trial. Financial report Sep 29, 2019 403
Immunomedics presents initial data from Phase 1b FORWARD II triplet cohort. Sep 29, 2019 196
ImmunoGen reports 83% overall response rate for Phase 1b triplet cohort. Sep 29, 2019 196
ImmunoGen presents initial data from Phase 1b FORWARD II triplet cohort. Sep 29, 2019 196
Roche's Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma. Sep 27, 2019 1919
Seattle Genetics (NASDAQ: SGEN). Sep 25, 2019 1844
GlaxoSmithKline (LSE: GSK). Sep 24, 2019 16577
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress. Sep 23, 2019 1237
Case Study of TK216 in Ewing Sarcoma Given at the Children's Oncology Group Meeting. Sep 20, 2019 617
ImmunoGen to Present Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine and Initial Data from Phase 1b FORWARD II Triplet Cohort at ESMO. Sep 19, 2019 234
Global Breast Cancer Drug Market Review & Forecast, 2017-2026. Sep 19, 2019 938
Seattle Genetics (NASDAQ: SGEN). Sep 19, 2019 1806
Soft Tissue Sarcoma Market Size 2019, Global Industry Overview, Share, Growth, Competitive Landscape, Key Players, Regional Forecast to 2023. Industry overview Sep 17, 2019 1047
Oncternal Therapeutics reports objective response to TK216 in Ewing sarcoma case. Sep 17, 2019 167
Global Colorectal Cancer Market Review & Outlook (2017-2026). Sep 16, 2019 745
AstraZeneca redefines cancer treatment with practice-changing data at ESMO 2019. Sep 16, 2019 2008
Merck announces new data from oncology portfolio at ESMO. Sep 9, 2019 378
Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma. Sutaria, Ravi; Patel, Parit; Danve, Abhijeet Sep 1, 2019 1595
What the Oncologist Needs From the Pathologist for Tyrosine Kinase Inhibitor Therapies. Bernicker, Eric H. Sep 1, 2019 3752
Invasive bilateral breast cancer and high grade serous ovarian cancer with BRCA1-germline mutation and brainstem metastasis under PARP inhibitors. Zahari, Mihaela Marioara; Chiorean, Angelica Rita; Duma, Maria Magdalena; Ungureanu, Andrei; Kacso, Sep 1, 2019 2247
Risk-based Algorithm-guided Treatment Protocol for the Management of Neovascular Age-related Macular Degeneration. Karacorlu, Murat; Hocaoglu, Mumin; Arf, Serra; Ersoz, M. Giray; Muslubas, Isil Sayman Sep 1, 2019 9577
Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events. Swami, Umang; Monga, Varun; Bossler, Aaron D.; Zakharia, Yousef; Milhem, Mohammed Aug 31, 2019 3740
Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration. Huizer, Karin; Sacchetti, Andrea; Dik, Wim A.; MustafaQ, Dana A.; Kros, Johan M. Aug 31, 2019 10159
IGF-1R Inhibition Suppresses Cell Proliferation and Increases Radiosensitivity in Nasopharyngeal Carcinoma Cells. Wang, Zhe; Liu, Guangyan; Mao, Jiwei; Xie, Min; Zhao, Ming; Guo, Xuefen; Liang, Shanshan; Li, Heming Aug 31, 2019 5770
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016). Widemann, Brigitte C.; Lu, Yao; Reinke, Denise; Okuno, Scott H.; Meyer, Christian F.; Cote, Gregory Aug 31, 2019 4706
Emerging Risk Profile of Lung Cancer Therapy: Diffuse Alveolar Hemorrhage from Osimertinib. Forte, Michael J.; Sangani, Rahul G. Aug 31, 2019 2686
Ileal Adenocarcinoma with Liver Metastasis in Patient with Crohn's Disease: A 9-Year Survival. Kothadia, Jiten P.; Nagaraju, Deepa H.; Katz, Seymour; Bruckner, Howard; Itzkowitz, Steven H.; Schwa Aug 31, 2019 3027
Management of Choroidal Neovascularization Associated with Optic Disc Melanocytoma with Intravitreal Aflibercept: A Case Report and Review of the Literature. Hamza, Hany S.; Moussa, Magdy; Elhusseiny, Abdelrahman M. Aug 31, 2019 1478
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa. Aloe, G.; De Sanctis, C.M.; Strafella, C.; Cascella, R.; Missiroli, F.; Cesareo, M.; Giardina, E.; R Aug 31, 2019 2886
Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye? Xu, Wei; Cheng, Weijing; Yao, Yao; Guo, Jian; Xu, Guoxing Aug 31, 2019 3898
Seattle Genetics (NASDAQ: SGEN). Aug 29, 2019 1805
Alvotech and Prestige Biopharma announce new manufacturing partnership. Aug 27, 2019 499
Chugai Pharmaceutical Co., Ltd. - Tecentriq, an Anti-PD-L1 Antibody, Receives Approval for Additional Indication of Extensive-Stage Small Cell Lung Cancer -- 22/8/2019. Aug 27, 2019 727
Adult Malignant Glioma Therapeutics Market Size, Share, Trends and Future Growth Predictions and For. Aug 23, 2019 1071
Global Glioblastoma Multiforme Treatment Market Estimated to grow With a CAGR of 11% During the Forecast Period, 2019-2024. Aug 23, 2019 902
Adult Malignant Glioma Therapeutics Market Size, Share, Trends and Future Growth Predictions and For. Aug 22, 2019 1084
Merck--LYNPARZA[R] (olaparib) Phase 3 PAOLA-1 Trial Met Primary Endpoint as First-Line Maintenance Treatment with Bevacizumab for Advanced Ovarian Cancer--14/8/2019. Aug 22, 2019 461
Global Soft Tissue Sarcoma Market to Exhibit 8.2% CAGR by 2023, Increase Prevalence Rate Fueling the Demand for Soft Tissue Sarcoma Treatment. Aug 21, 2019 1056
Seattle Genetics (NASDAQ: SGEN). Aug 20, 2019 1806
Merck & Company, Inc. (NYSE:MRK) - LYNPARZA[R] (olaparib) Phase 3 PAOLA-1 Trial Met Primary Endpoint as First-Line Maintenance Treatment with Bevacizumab for Advanced Ovarian Cancer -- 14/8/2019. Aug 20, 2019 465
AstraZeneca (NYSE: AZN) - AstraZeneca and MSD's Lynparza, when added to standard-of-care bevacizumab, significantly increased the time women lived without disease progression -- 14/8/2019. Aug 20, 2019 462
Lynparza Phase III Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment with Bevacizumab for Advanced Ovarian Cancer. Aug 16, 2019 318
Creative Biogene Offered Ovarian Cancer Pathway as well as Related Products to Accelerate The Drug Discovery Projects. Aug 15, 2019 593
AstraZeneca and MSD reveal phase three trial results for Lynparza in combination with bevacizumab. Aug 15, 2019 170
AstraZeneca and MSD reveal phase three trial results for Lynparza in combination with bevacizumab. Aug 15, 2019 166
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer. Aug 14, 2019 1681
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering. Aug 14, 2019 1112
TOP NEWS: AstraZeneca Leukaemia Drug Gets US Regulatory Designation. Aug 14, 2019 406
Merck, AstraZeneca: LYNPARZA Phase 3 PAOLA-1 trial met primary endpoint. Aug 14, 2019 133
AstraZeneca, Merck announce PAOLA-1 meets primary endpoint in ITT population. Aug 14, 2019 133
Seattle Genetics (NASDAQ: SGEN). Aug 13, 2019 1806
Seattle Genetics (NASDAQ: SGEN). Jul 31, 2019 1808
An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab. Lee, Matthew; Seetharamu, Nagashree Jul 31, 2019 3469
All you need to know about DR. Jul 30, 2019 510
Alvotech and Cipla gulf into a partnership for the commercialization of key biosimilar in select emerging markets. Jul 29, 2019 608
Anti-Angiogenic Activity of Flunarizine by In Ovo, In Vitro, and In Vivo Assays/In Ovo, In Vitro ve In Vivo Gunluklerinden Flunarizinin Anti-Anjiyojenik Aktivitesi. Kamili, Chandana; Kakaraparthy, Ravi Shankar; Vattikuti, Uma Maheshwararao Jul 25, 2019 3770
Amgen (NASDAQ: AMGN) - Amgen And Allergan's MVASI[TM] (bevacizumab-awwb) And KANJINTI[TM] (trastuzumab-anns) Now Available In The United States -- 18/7/2019. Jul 25, 2019 757
Seattle Genetics (NASDAQ: SGEN). Jul 25, 2019 1844
Amgen (NASDAQ:AMGN) - Amgen And Allergan's MVASI[TM] (bevacizumab-awwb) And KANJINTI[TM] (trastuzumab-anns) Now Available In The United States -- 18/7/2019. Jul 22, 2019 743
Amgen and Allergan announce availability of MVASI and KANJINTI in the US for the treatment of multiple cancers. Jul 19, 2019 277
Amgen and Allergan announce availability of MVASI and KANJINTI in the US for the treatment of multiple cancers. Jul 19, 2019 273
Seattle Genetics (NASDAQ: SGEN). Jul 17, 2019 1844
Adult Malignant Glioma Therapeutics Market Size, Share, Trends and Future Growth Predictions and For. Jul 17, 2019 1052
Trovagene begins enrollment of Phase 1b/2 study of onvansertib. Jul 9, 2019 102
Pfizer Receives US FDA Approval for Its Oncology Biosimilar, Zirabev. Jul 2, 2019 322
US FDA approves Pfizer's Zirabev. Jul 2, 2019 157
US FDA approves Pfizer's Zirabev. Jul 2, 2019 153
Asparagus Polysaccharide Suppresses the Migration, Invasion, and Angiogenesis of Hepatocellular Carcinoma Cells Partly by Targeting the HIF-1[alpha]/VEGF Signalling Pathway In Vitro. Cheng, Wei; Cheng, Ziwei; Xing, Dongwei; Zhang, Minguang Jun 30, 2019 5581
Myocardial Infarction after Long-Term Treatment with a Tyrosine Kinase Inhibitor (TKI) with Anti-VEGF Receptor Activity. Paschke, L.; Lincke, T.; Muhlberg, K.; Lindner, Tom H.; Paschke, R. Jun 30, 2019 2036
Robot-Assisted Infratrigonal Vesicovaginal Fistula Repair. Manzano, Joao Padua; Crochik, Fabio da Silva; Pugliesi, Felipe Guimaraes; de Almeida, Renato Vasconc Jun 30, 2019 2418
Treatment Outcomes in Anaplastic Thyroid Cancer. Corrigan, Kelsey L.; Williamson, Hannah; Range, Danielle Elliott; Niedzwiecki, Donna; Brizel, David Jun 30, 2019 6299
Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity. Chen, Xuting; Zhou, Lin; Zhang, Qi; Xu, Yu; Zhao, Peiquan; Xia, Hongping Jun 30, 2019 3705
Factors That Influence Refractive Changes in the First Year of Myopia Development in Premature Infants. Mao, Jianbo; Lao, Jimeng; Liu, Chenyi; Wu, Mingyuan; Yu, Xueting; Shao, Yirun; Zhu, Lin; Chen, Yiqi; Jun 30, 2019 4685
Pfizer announces FDA approval for Zirabev for treatment of five types of cancer. Jun 28, 2019 102
AstraZeneca announces Japanese approval for Lynparza for first-line maintenance. Jun 20, 2019 237
AstraZeneca reports approval for Lynparza in the EU for first -line maintenance treatment of BRCA-mutated advanced ovarian cancer. Jun 19, 2019 296
TOP NEWS: EU Approve AstraZeneca's Lynparza In Advanced Ovarian Cancer. Jun 18, 2019 322
LONDON MARKET MIDDAY: Dovish ECB Draghi Gives Stocks Helping Hand. Jun 18, 2019 1158
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES)--CASE REPORT & REVIEW OF LITERATURE. Raman, Sarojini; Behera, Chinmay Kumar; Senapati, Urmila Jun 17, 2019 2771
Adult Malignant Glioma Therapeutics Market Analysis, Size, Share, Growth, Trends, and Forecast 2018. Jun 10, 2019 1057
Adult Malignant Glioma Therapeutics Market Analysis, Size, Share, Growth, Trends, and Forecast 2018. Jun 10, 2019 1044
VBL Therapeutics presents VB-111 data at ASCO. Jun 3, 2019 184
VBL Therapeutics presents final VB-111 trial results at ASCO. Jun 3, 2019 158
DelMar Pharmaceuticals provides update on VAL-083 studies. Jun 3, 2019 472
MEI Pharma presents results for ME-344 in combination with Bevacizumab. Clinical report Jun 2, 2019 279
PERIOPERATIVE CHANGES IN LYMPHOCYTE SUBPOPULATIONS IN PATIENTS UNDERGOING SURGERY FOR COLORECTAL CANCER. Rubinkiewicz, Mateusz; Sieminska, Izabela; Malczak, Piotr; Major, Piotr; Baran, Jaroslaw; Budzyriski Jun 1, 2019 3174
Targeted Agents and Resistance Mechanism in Renal Cell Cancer. Rezapourbehnagh, Shaghayegh; Yasar, Hatime Arzu; Arslan, Cagatay; Urun, Yuksel Jun 1, 2019 6190
Radyoembolizasyon: Hasta Secimi ve Planlama/Radioembolization: Patient Selection and Planning. Guney, Isa Burak; Balli, Huseyin Tugsan Jun 1, 2019 5046
Radyoembolizasyon Tedavisinde Yanit Degerlendirme: Tuzaklar ve Standardizasyon/Assessment of Radioembolization Treatment Response: Standardization, Tips & Tricks. Yakupoglu, Abdullah Jun 1, 2019 2834
Metastatik Karaciger Kanseri Tedavisinde Radyoembolizasyon/Radioembolization in the Treatment of Metastatic Liver Cancer. Kucuk, Nuriye Ozlem; Akkus, Pinar Clinical report Jun 1, 2019 3003

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters